ZoomInfo Technologies Inc Reveals Advance In Q4 Income

ZoomInfo reported stronger Q4 results with GAAP net income of $34.7 million ($0.11/share) versus $14.6 million ($0.04) a year ago, and adjusted earnings of $106.2 million ($0.32/share). Revenue rose 3.2% to $319.1 million from $309.1 million a year earlier. Management guided Q1 EPS $0.25–$0.27 and revenue $306–$309 million, and provided FY2026 guidance of $1.247–$1.267 billion in revenue with adjusted net income per share of $1.10–$1.12, indicating modest top-line growth but improving profitability that should be factored into near-term valuation and trading decisions.

Analysis

Market structure: ZoomInfo (GTM) is a near-term beneficiary of durable B2B data demand — 3.2% YoY revenue growth with materially higher adjusted EPS ($0.32) signals margin expansion and pricing power versus legacy directory providers. Winners: digital-first GTM and martech integrators; losers: incumbents reliant on manual enrichment or heavy offline channels. Cross-asset: modest positive for IG tech credit spreads and equity implied-vol compression; FX/commodities impact negligible.

Risk assessment: Tail risks include regulatory/privacy shocks (GDPR/CPRA-style restrictions within 6-18 months) and a macro-driven 10-20% cut in client marketing budgets that could impair ARR. Short-term (days–weeks) risk is guidance repricing; medium-term (quarters) is customer churn and integration execution; long-term (years) depends on product moat and data-source resiliency. Hidden dependency: reliance on third-party enrichment and intent data pipelines creates single-point failure risk.

Trade implications: Direct trade — establish a 1.5–3.0% long position in GTM sized to risk budget with a 6–12 month horizon; trim if next-quarter revenue guidance prints below $306M or FY midpoint < $1.247B. Pair trade — long GTM / short DNB (DNB) size 0.7–1.0x to capture digital-vs-legacy dispersion. Options — buy a 6-month call spread 20–30% OTM (max loss ~1% portfolio) to lever upside; sell 30–60 day covered calls if owning shares to capture IV.

Contrarian angles: Consensus underestimates privacy/regulatory friction and may overpay for near-term revenue stability; conversely, the margin beat suggests upside is underpriced if GTM converts upsells to ARR. Historical parallel: post-GDPR selloffs in data names created 6–9 month buying windows for survivors. Unintended risk: aggressive AI/integration spend could compress margins if monetization lags beyond 12 months.

Key Decisions for Investors

• Establish a 1.5–3.0% long position in GTM with a 6–12 month horizon; set hard exits: cut to zero if next-quarter revenue < $306M or FY revenue midpoint < $1.247B, take profits at +25–35%.
• Implement a pair trade: long GTM / short Dun & Bradstreet (DNB) at a 0.7–1.0x notional ratio, target 12% relative outperformance over 3–9 months, widest stop if GTM underperforms by 10% absolute.
• Purchase a 6-month call spread on GTM 20–30% out-of-the-money sized to 0.8–1.2% of portfolio (defined-risk); simultaneously sell 30–60 day covered calls against up to 50% of long shares to harvest near-term IV.
• Monitor regulatory signals (CPRA/UK/EU e-privacy updates) over the next 30–90 days — if major restrictive text is proposed/passed, reduce GTM exposure by 50% within 2 weeks; if nothing materializes and ARR growth accelerates sequentially, scale longs by another 1%.